Deepak Kanojia

researcher

Born 2000-01-01

Deepak Kanojia is …
instance of (P31):
humanQ5

External links are
P2798Loop ID501711
P496ORCID iD0000-0003-4295-4972
P3829Publons author ID1364944
P1053ResearcherIDG-5120-2014
P1153Scopus author ID12759559300

P69educated atHomi Bhabha National InstituteQ3532663
Maharaja Sayajirao University of BarodaQ1747272
P108employerUniversity of ChicagoQ131252
University of South CarolinaQ1024426
P735given nameDeepakQ1182436
DeepakQ1182436
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q363828884-nitroquinoline-1-oxide induced experimental oral carcinogenesis.
Q38675900A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model.
Q35658592A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma
Q36367252A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors
Q98733388BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Q45831647BMET-40NANO PLATFORM FOR DYNAMIC IN VIVO TRACKING OF NEURAL STEM CELLS TO BRAIN METASTASES OF BREAST CANCER.
Q40619963CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Q35678242CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Q50033953CORRIGENDUM: Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy.
Q38819741Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma
Q55710105ET-05INTRANASAL DELIVERY OF NEURAL STEM CELLS LOADED WITH ONCOLYTIC ADENOVIRUS EXTENDS SURVIVAL OF MICE WITH INTRACRANIAL GLIOMA.
Q92035705FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis
Q47141309Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
Q37274612Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
Q80971228Keratins: markers of cell differentiation or regulators of cell differentiation?
Q89840115Landscape of combination therapy trials in breast cancer brain metastasis
Q38702903Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Q36083446Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.
Q39023173Neural stem cell-mediated delivery of oncolytic adenovirus.
Q42560600Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy
Q54291180Proteomic profiling of cancer stem cells derived from primary tumors of HER2/Neu transgenic mice.
Q36904198Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters
Q26850467Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
Q55073445Type II PtdIns 4-kinase β associates with CD4-p56lck complex and is involved in CD4 receptor signaling.
Q35657822Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy
Q35587344βIII-Tubulin Regulates Breast Cancer Metastases to the Brain.

Search more.